Your browser doesn't support javascript.
loading
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.
Rizzo, Manfredi; Nikolic, Dragana; Patti, Angelo Maria; Mannina, Carlo; Montalto, Giuseppe; McAdams, Brooke S; Rizvi, Ali A; Cosentino, Francesco.
Afiliação
  • Rizzo M; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy; Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia 29203, SC, USA. Electronic address: manfredi.rizzo@unipa.it.
  • Nikolic D; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
  • Patti AM; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
  • Mannina C; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy.
  • Montalto G; Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy. Electronic address: giuseppe.montalto@unipa.it.
  • McAdams BS; Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia 29203, SC, USA.
  • Rizvi AA; Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia 29203, SC, USA. Electronic address: ali.rizvi@uscmed.sc.edu.
  • Cosentino F; Unit of Cardiology, Department of Medicine, Karolinska Institute & Karolinska University Hospital Solna, S1:02 171 76 Stockholm, Sweden. Electronic address: francesco.cosentino@ki.se.
Biochim Biophys Acta Mol Basis Dis ; 1864(9 Pt B): 2814-2821, 2018 09.
Article em En | MEDLINE | ID: mdl-29778663
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Placa Aterosclerótica / Receptor do Peptídeo Semelhante ao Glucagon 1 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Diabetes Mellitus Tipo 2 / Incretinas / Placa Aterosclerótica / Receptor do Peptídeo Semelhante ao Glucagon 1 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article